Consistent with this, our acquired and intrinsic TMZ-resistant GBM cells showed a robust increase in CLK2 protein expression as compared to the TMZ-sensitive line (Fig. 4E), but acute TMZ treatment of TMZ-sensitive cells did not increase CLK2 protein expression (Fig. 4E). The gene discussed is CLK2; the disease is glioblastoma.